Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection.
Sumit K MattaPhilipp OliasZhou HuangQiuling WangEugene ParkWayne M YokoyamaL David SibleyPublished in: Proceedings of the National Academy of Sciences of the United States of America (2019)
In contrast to the importance of type II interferon-γ (IFN-γ) in control of toxoplasmosis, the role of type I IFN is less clear. We demonstrate here that TgIST, a secreted effector previously implicated in blocking type II IFN-γ signaling, also blocked IFN-β responses by inhibiting STAT1/STAT2-mediated transcription in infected cells. Consistent with a role for type I IFN in cell intrinsic control, ∆Tgist mutants were more susceptible to growth inhibition by murine and human macrophages activated with IFN-β. Additionally, type I IFN was important for production of IFN-γ by natural killer (NK) cells and recruitment of inflammatory monocytes at the site of infection. Mice lacking type I IFN receptors (Ifnar1-/-) showed increased mortality following infection with wild-type parasites and decreased virulence of ∆Tgist parasites was restored in Ifnar1-/- mice. The findings highlight the importance of type I IFN in control of toxoplasmosis and illuminate a parasite mechanism to counteract the effects of both type I and II IFN-mediated host defenses.
Keyphrases
- dendritic cells
- immune response
- toxoplasma gondii
- regulatory t cells
- wild type
- endothelial cells
- stem cells
- cell proliferation
- staphylococcus aureus
- nk cells
- cardiovascular disease
- single cell
- risk factors
- signaling pathway
- cardiovascular events
- cell death
- induced apoptosis
- cystic fibrosis
- transcription factor
- metabolic syndrome
- mesenchymal stem cells
- antimicrobial resistance
- candida albicans
- pluripotent stem cells
- cell cycle arrest